Welcome to hiintermediates.com,intermediates trading platform
Home > products > 1H-1-Benzazepine-1-aceticacid,3-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-,hydrochloride (1:1), (3S)-

1H-1-Benzazepine-1-aceticacid,3-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-,hydrochloride (1:1), (3S)- cas no:86541-74-4

Synonyms: 1H-1-Benzazepine-1-aceticacid,3-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-,monohydrochloride, (3S)- (9CI);1H-1-Benzazepine-1-acetic acid,3-[[1-(ethoxycarbonyl)-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-,monohydrochloride, [S-(R*,R*)]-;CGS 14824A;CGS14824A HCl;Lotensin;Lotension;

Identification
Name1H-1-Benzazepine-1-aceticacid,3-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-,hydrochloride (1:1), (3S)-
CAS86541-74-4
Synonyms1H-1-Benzazepine-1-aceticacid,3-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-,monohydrochloride, (3S)- (9CI);1H-1-Benzazepine-1-acetic acid,3-[[1-(ethoxycarbonyl)-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-,monohydrochloride, [S-(R*,R*)]-;CGS 14824A;CGS14824A HCl;Lotensin;Lotension;
Molecular FormulaC24H29ClN2O5
Molecular Weight460.95046
Chemical Properties
AppearanceCrystalline Solid
storage tempDesiccate at +4°C
Safety Data

Safety

Safety Information:
Safety Statements: 22-24/25
22: Do not breathe dust?
24/25:Avoid contact with skin and eyes?
WGK Germany: 2
RTECS: CX7065000
Hazardous Substances Data: 86541-74-4(Hazardous Substances Data)


Toxicity

CHEMICAL IDENTIFICATION

RTECS NUMBER :
CX7065000
CHEMICAL NAME :
1H-1-Benzazepine-1-acetic acid, 2,3,4,5-tetrahydro-3-((1-(ethoxycarbonyl)-3-phenylpro pyl) amino)-2-oxo-, monohydrochloride, (S-(R*,R*))-
CAS REGISTRY NUMBER :
86541-74-4
LAST UPDATED :
199512
DATA ITEMS CITED :
8
MOLECULAR FORMULA :
C24-H28-N2-O5.Cl-H
MOLECULAR WEIGHT :
461.00

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
>5 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
CDREEA Cardiovascular Drug Reviews. (Raven Press, 1185 Avenue of the Americas, New York, NY 10036) V.6- 1988- Volume(issue)/page/year: 8,89,1990
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
4019 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
CDREEA Cardiovascular Drug Reviews. (Raven Press, 1185 Avenue of the Americas, New York, NY 10036) V.6- 1988- Volume(issue)/page/year: 8,89,1990
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
1 gm/kg
TOXIC EFFECTS :
Sense Organs and Special Senses (Olfaction) - effect, not otherwise specified Behavioral - food intake (animal) Gastrointestinal - nausea or vomiting
REFERENCE :
CDREEA Cardiovascular Drug Reviews. (Raven Press, 1185 Avenue of the Americas, New York, NY 10036) V.6- 1988- Volume(issue)/page/year: 8,89,1990 ** OTHER MULTIPLE DOSE TOXICITY DATA **
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
3650 mg/kg/1Y-C
TOXIC EFFECTS :
Behavioral - food intake (animal) Liver - changes in liver weight Blood - changes in serum composition (e.g. TP, bilirubin, cholesterol)
REFERENCE :
YACHDS Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- Volume(issue)/page/year: 19,3863,1991
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
54750 mg/kg/1Y-C
TOXIC EFFECTS :
Kidney, Ureter, Bladder - changes primarily in glomeruli Kidney, Ureter, Bladder - changes in tubules (including acute renal failure, acute tubular necrosis) Blood - changes in spleen
REFERENCE :
YACHDS Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- Volume(issue)/page/year: 19,3893,1991 ** REPRODUCTIVE DATA **
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
81 gm/kg
SEX/DURATION :
male 60 day(s) pre-mating female 2 week(s) pre-mating - 7 day(s) after conception
TOXIC EFFECTS :
Reproductive - Maternal Effects - other effects Reproductive - Fertility - pre-implantation mortality (e.g. reduction in number of implants per female; total number of implants per corpora lutea) Reproductive - Effects on Embryo or Fetus - fetal death
REFERENCE :
YACHDS Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- Volume(issue)/page/year: 19,3445,1991
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
26 gm/kg
SEX/DURATION :
female 17-21 day(s) after conception lactating female 21 day(s) post-birth
TOXIC EFFECTS :
Reproductive - Maternal Effects - parturition Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight gain) Reproductive - Effects on Newborn - delayed effects
REFERENCE :
YACHDS Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- Volume(issue)/page/year: 19,3471,1991
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
11 gm/kg
SEX/DURATION :
female 7-17 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - eye/ear Reproductive - Specific Developmental Abnormalities - urogenital system Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight gain)
REFERENCE :
YACHDS Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972- Volume(issue)/page/year: 19,3453,1991

supplier list

Tai zhou world Pharm & Chem Co., Ltd.
Tel:
Address: Rome 1001,wangjiang plaza,unti 2,jinshan east Road linhai,zhejiang,china
Sris Pharmaceuticals
Tel:+91-(40)-23061913
Address: Plot No.2-22-68,G-3,Sailakshmi Residency, Vijayanagar Colony,Vivekananda Nagar, Kukatpally, Hyderabad, Andhra Pradesh 500 072,
Nanjing Bangnuo Biotechnology Co., Ltd
Tel:86-1732-7098554
Address: shuanglong road,jiangning, nanjing,jiangsu
Nanjing Bangnuo Biotechnology Co., Ltd
Tel:86-1732-7098554
Address: shuanglong road,jiangning, nanjing,jiangsu
Hubei XinRunde Chemical Co., Ltd
Tel:86-27-83214668
Address: East and West Lake District, Wuhan, China
Nanjing Bangnuo Biotechnology Co., Ltd.
Tel:86-25-52113793
Address: Room 901 Tianqinwan Garden NO.1008 Ssangyong Avenu
Shanghai Do Chemical Co.,Ltd
Tel:86-21-33758180
Address: No 350,Guoshoujing Road, Zhangjiang Hi-tech Park, Pudong, Shanghai, China
Wuhan Dahua Weiye Pharmaceutical Co.,Ltd
Tel:86-27-59335372
Address: daijiashan 45,jiangan economic departmen zone,wuhan,hubei,China
Wuhan Senwayer Century chemical Co.,Ltd
Tel:86-27-59009407
Address: 20#Xudong Street,Wuhan China
Wuhan Senwayer Century chemical Co.,Ltd
Tel:86-27-59009407
Address: 20#Xudong Street,Wuhan China
Jinan Jianfeng Chemical Co., Ltd
Tel:86-531-88110457
Address: Huaneng Road, Licheng District, Jinan City, Shandong Pro., China
Hangzhou Dayangchem Co., Ltd.
Tel:86-571-88938639
Address: 9/F Unit 2 ChangdiTorch Building, 259 #WenSan Road
Hangzhou J&H Chemical Co., Ltd
Tel:86-571-87396430
Address: No.200 Zhenhua Rd.Xihu Industrial Park, Hangzhou 310030, China
Finetech Industry limited.
Tel:86-27-87465837
Address: chukang Road, Wuhan, Hubei 430073,
Jinlan Pharm-Drugs Technology Co., Limited
Tel:86-571-85829152
Address: Room 606, Fuyi Center, #298 Quanfuqiao Road, Jiang

Home   |   About Us   |   Service   |   Links   |   Add to  Favorite

Copyright©2011 HiIntermediates ICP: B2-20090288 浙ICP备09045134号-49
Tel: +86-0571-89739792